Bottom line
Is PBMRX a good fund? The bottom line
PBMRX is the Investor Class share class of Polen U.S. SMID Company Growth Fund, a managed small-cap mutual fund from Fundvantage.
Annual fees run 1.3% — about $130 a year on every $10,000 invested, more expensive than 77% of small-cap funds we track.
What to watch
- Expensive for its category (1.3%)
Updated Nov 19, 2026
What PBMRX invests in
Polen U.S. SMID Company Growth Fund (the Fund) seeks to achieve long-term growth of capital.
The Fund typically invests in a portfolio of common stocks of small and mid-cap companies and, under normal circumstances, the Fund invests at least 80% of its net assets in securities of U.S. issuers that are small or mid-cap companies. This 80% policy to invest in small and mid-cap companies may be changed by the Board of Trustees without shareholder approval upon 60 days notice to shareholders. The Adviser considers small and mid-cap companies for this purpose to be those companies that, at the time of purchase, are within the range of the market capitalizations of companies in the Russell 2500 Growth Index. This policy does not require the Fund to sell the security of a small or mid-cap company if such companys market capitalization moves outside the range of the market capitalizations of companies in the Russell 2500 Growth Index; however, additional purchases of such security…
From the fund's prospectus (filed Aug 28, 2025).
What PBMRX costs
On a $10,000 investment, PBMRX's 1.3% expense ratio costs about $130 a year. The prospectus estimates $2,601 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.